首页 正文

Targeting oncogenic TβRI signaling inhibits androgen-independent prostate cancer growth and metastasis

{{output}}
Metastatic castration-resistant prostate cancer (mCRPC) remains the primary cause of prostate cancer-related mortality. Despite the availability of treatments, the molecular mechanisms underlying tumor invasion and metastasis are not fully understood, highligh... ...